APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Over the Counter (OTC) Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025199 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Analgesics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Analgesics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Over the Counter (OTC) Analgesics include Takeda Pharmaceutical Company Limited., Sanofi SA, Johnson & Johnson, Novartis, Pfizer, Bayer AG, AstraZeneca, Sun Pharma and Reckitt Benckiser Group PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Over the Counter (OTC) Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Over the Counter (OTC) Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Over the Counter (OTC) Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Over the Counter (OTC) Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Over the Counter (OTC) Analgesics Segment by Company

Takeda Pharmaceutical Company Limited.

Sanofi SA

Johnson & Johnson

Novartis

Pfizer

Bayer AG

AstraZeneca

Sun Pharma

Reckitt Benckiser Group PLC

GlaxoSmithKline PLC

Boehringer Ingelheim International GmbH

Over the Counter (OTC) Analgesics Segment by Type

Tablet

Capsule

Other

Over the Counter (OTC) Analgesics Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Over the Counter (OTC) Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Over the Counter (OTC) Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Over the Counter (OTC) Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Over the Counter (OTC) Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Over the Counter (OTC) Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Over the Counter (OTC) Analgesics Industry Trends Table 2. Over the Counter (OTC) Analgesics Industry Drivers Table 3. Over the Counter (OTC) Analgesics Industry Opportunities and Challenges Table 4. Over the Counter (OTC) Analgesics Industry Restraints Table 5. Global Over the Counter (OTC) Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Over the Counter (OTC) Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Over the Counter (OTC) Analgesics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturers Table 9. Global Over the Counter (OTC) Analgesics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Over the Counter (OTC) Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Over the Counter (OTC) Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Over the Counter (OTC) Analgesics Manufacturers, Product Type & Application Table 13. Global Over the Counter (OTC) Analgesics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Over the Counter (OTC) Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Capsule Table 18. Major Manufacturers of Other Table 19. Global Over the Counter (OTC) Analgesics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 21. Global Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 22. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2021-2026) Table 23. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2027-2032) Table 24. Global Over the Counter (OTC) Analgesics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Over the Counter (OTC) Analgesics Revenue by Type (2021-2026) & (K Units) Table 26. Global Over the Counter (OTC) Analgesics Revenue by Type (2027-2032) & (K Units) Table 27. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2021-2026) Table 28. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Online Pharmacies Table 31. Major Manufacturers of Hospital Pharmacies Table 32. Global Over the Counter (OTC) Analgesics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 34. Global Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 35. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2021-2026) Table 36. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2027-2032) Table 37. Global Over the Counter (OTC) Analgesics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Over the Counter (OTC) Analgesics Revenue by Application (2021-2026) & (K Units) Table 39. Global Over the Counter (OTC) Analgesics Revenue by Application (2027-2032) & (K Units) Table 40. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2021-2026) Table 41. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2027-2032) Table 42. Global Over the Counter (OTC) Analgesics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Over the Counter (OTC) Analgesics Sales by Region (2021-2026) & (K Units) Table 44. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2021-2026) Table 45. Global Over the Counter (OTC) Analgesics Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Over the Counter (OTC) Analgesics Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 49. North America Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 50. Europe Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 52. Europe Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 59. Global Over the Counter (OTC) Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Over the Counter (OTC) Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Over the Counter (OTC) Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2021-2026) Table 63. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2027-2032) Table 64. Takeda Pharmaceutical Company Limited. Company Information Table 65. Takeda Pharmaceutical Company Limited. Business Overview Table 66. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio Table 68. Takeda Pharmaceutical Company Limited. Recent Development Table 69. Sanofi SA Company Information Table 70. Sanofi SA Business Overview Table 71. Sanofi SA Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio Table 73. Sanofi SA Recent Development Table 74. Johnson & Johnson Company Information Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio Table 78. Johnson & Johnson Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novartis Over the Counter (OTC) Analgesics Product Portfolio Table 83. Novartis Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Over the Counter (OTC) Analgesics Product Portfolio Table 88. Pfizer Recent Development Table 89. Bayer AG Company Information Table 90. Bayer AG Business Overview Table 91. Bayer AG Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Bayer AG Over the Counter (OTC) Analgesics Product Portfolio Table 93. Bayer AG Recent Development Table 94. AstraZeneca Company Information Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio Table 98. AstraZeneca Recent Development Table 99. Sun Pharma Company Information Table 100. Sun Pharma Business Overview Table 101. Sun Pharma Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio Table 103. Sun Pharma Recent Development Table 104. Reckitt Benckiser Group PLC Company Information Table 105. Reckitt Benckiser Group PLC Business Overview Table 106. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio Table 108. Reckitt Benckiser Group PLC Recent Development Table 109. GlaxoSmithKline PLC Company Information Table 110. GlaxoSmithKline PLC Business Overview Table 111. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio Table 113. GlaxoSmithKline PLC Recent Development Table 114. Boehringer Ingelheim International GmbH Company Information Table 115. Boehringer Ingelheim International GmbH Business Overview Table 116. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio Table 118. Boehringer Ingelheim International GmbH Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Over the Counter (OTC) Analgesics Distributors List Table 122. Over the Counter (OTC) Analgesics Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Over the Counter (OTC) Analgesics Product Image Figure 2. Global Over the Counter (OTC) Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over the Counter (OTC) Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Over the Counter (OTC) Analgesics Sales (2021-2032) & (K Units) Figure 5. Global Over the Counter (OTC) Analgesics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Over the Counter (OTC) Analgesics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Capsule Image Figure 10. Other Image Figure 11. Global Over the Counter (OTC) Analgesics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Over the Counter (OTC) Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2021-2032) Figure 14. Global Over the Counter (OTC) Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Over the Counter (OTC) Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2021-2032) Figure 17. Retail Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Hospital Pharmacies Image Figure 20. Global Over the Counter (OTC) Analgesics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Over the Counter (OTC) Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2021-2032) Figure 23. Global Over the Counter (OTC) Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Over the Counter (OTC) Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2021-2032) Figure 26. North America Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2032) Figure 28. U.S. Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2032) Figure 33. Germany Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2032) Figure 40. China Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2032) Figure 48. Brazil Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Over the Counter (OTC) Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Figure 59. North America Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Figure 61. Europe Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Over the Counter (OTC) Analgesics Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Over the Counter (OTC) Analgesics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Takeda Pharmaceutical Company Limited.
  • Sanofi SA
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Bayer AG
  • AstraZeneca
  • Sun Pharma
  • Reckitt Benckiser Group PLC
  • GlaxoSmithKline PLC
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Over the Counter (OTC) Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Over the Counter (OTC) Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Over the Counter (OTC) Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Over the Counter (OTC) Analgesics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Over the Counter (OTC) Analgesics Market Dynamics
  1. 2.1 Over the Counter (OTC) Analgesics Industry Trends
  2. 2.2 Over the Counter (OTC) Analgesics Industry Drivers
  3. 2.3 Over the Counter (OTC) Analgesics Industry Opportunities and Challenges
  4. 2.4 Over the Counter (OTC) Analgesics Industry Restraints
3 Over the Counter (OTC) Analgesics Market by Manufacturers
  1. 3.1 Global Over the Counter (OTC) Analgesics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Over the Counter (OTC) Analgesics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Over the Counter (OTC) Analgesics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Over the Counter (OTC) Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Over the Counter (OTC) Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Over the Counter (OTC) Analgesics Manufacturers, Product Type & Application
  7. 3.7 Global Over the Counter (OTC) Analgesics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Over the Counter (OTC) Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Over the Counter (OTC) Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Over the Counter (OTC) Analgesics Tier 1, Tier 2, and Tier 3
4 Over the Counter (OTC) Analgesics Market by Type
  1. 4.1 Over the Counter (OTC) Analgesics Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.1.3 Other
  5. 4.2 Global Over the Counter (OTC) Analgesics Sales by Type
  6. 4.2.1 Global Over the Counter (OTC) Analgesics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Over the Counter (OTC) Analgesics Sales by Type (2021-2032)
  8. 4.2.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Over the Counter (OTC) Analgesics Revenue by Type
  10. 4.3.1 Global Over the Counter (OTC) Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2021-2032)
  12. 4.3.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2021-2032)
5 Over the Counter (OTC) Analgesics Market by Application
  1. 5.1 Over the Counter (OTC) Analgesics Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Over the Counter (OTC) Analgesics Sales by Application
  6. 5.2.1 Global Over the Counter (OTC) Analgesics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Over the Counter (OTC) Analgesics Sales by Application (2021-2032)
  8. 5.2.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Over the Counter (OTC) Analgesics Revenue by Application
  10. 5.3.1 Global Over the Counter (OTC) Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2021-2032)
  12. 5.3.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2021-2032)
6 Global Over the Counter (OTC) Analgesics Sales by Region
  1. 6.1 Global Over the Counter (OTC) Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Over the Counter (OTC) Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Over the Counter (OTC) Analgesics Sales by Region (2021-2026)
  4. 6.2.2 Global Over the Counter (OTC) Analgesics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Over the Counter (OTC) Analgesics Revenue by Region
  1. 7.1 Global Over the Counter (OTC) Analgesics Revenue by Region
  2. 7.1.1 Global Over the Counter (OTC) Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Over the Counter (OTC) Analgesics Revenue by Region (2021-2026)
  4. 7.1.3 Global Over the Counter (OTC) Analgesics Revenue by Region (2027-2032)
  5. 7.1.4 Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Over the Counter (OTC) Analgesics Revenue (2021-2032)
  8. 7.2.2 North America Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Over the Counter (OTC) Analgesics Revenue (2021-2032)
  11. 7.3.2 Europe Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Over the Counter (OTC) Analgesics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Over the Counter (OTC) Analgesics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Over the Counter (OTC) Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company Limited.
  2. 8.1.1 Takeda Pharmaceutical Company Limited. Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Limited. Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Limited. Recent Developments
  7. 8.2 Sanofi SA
  8. 8.2.1 Sanofi SA Company Information
  9. 8.2.2 Sanofi SA Business Overview
  10. 8.2.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio
  12. 8.2.5 Sanofi SA Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Over the Counter (OTC) Analgesics Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Over the Counter (OTC) Analgesics Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer AG
  32. 8.6.1 Bayer AG Company Information
  33. 8.6.2 Bayer AG Business Overview
  34. 8.6.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer AG Over the Counter (OTC) Analgesics Product Portfolio
  36. 8.6.5 Bayer AG Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 Reckitt Benckiser Group PLC
  50. 8.9.1 Reckitt Benckiser Group PLC Company Information
  51. 8.9.2 Reckitt Benckiser Group PLC Business Overview
  52. 8.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio
  54. 8.9.5 Reckitt Benckiser Group PLC Recent Developments
  55. 8.10 GlaxoSmithKline PLC
  56. 8.10.1 GlaxoSmithKline PLC Company Information
  57. 8.10.2 GlaxoSmithKline PLC Business Overview
  58. 8.10.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio
  60. 8.10.5 GlaxoSmithKline PLC Recent Developments
  61. 8.11 Boehringer Ingelheim International GmbH
  62. 8.11.1 Boehringer Ingelheim International GmbH Company Information
  63. 8.11.2 Boehringer Ingelheim International GmbH Business Overview
  64. 8.11.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio
  66. 8.11.5 Boehringer Ingelheim International GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Over the Counter (OTC) Analgesics Value Chain Analysis
  2. 9.1.1 Over the Counter (OTC) Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Over the Counter (OTC) Analgesics Production Mode & Process
  6. 9.2 Over the Counter (OTC) Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Over the Counter (OTC) Analgesics Distributors
  9. 9.2.3 Over the Counter (OTC) Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst